Bill
HB 40
Bill HB 40 eliminates cost-sharing for prostate cancer screenings for high-risk men, promoting early detection and improving health outcomes by removing financial barriers.
Title: Health Care Insurance; To Eliminate Cost-Sharing for Screening of Men Who Are at High Risk for Prostate Cancer
Bill Number: HB 40
Status: Read for the first time and referred to the House Committee on Insurance
Introduced: August 28, 2025
Classification: Bill
Subject: Insurance
The primary purpose of Bill HB 40 is to enhance access to prostate cancer screening for men who are identified as being at high risk for the disease. By eliminating cost-sharing requirements, the bill aims to encourage more individuals to undergo necessary screenings, thereby promoting early detection and potentially improving health outcomes.
Elimination of Cost-Sharing: The bill mandates that health insurance plans must cover the costs associated with prostate cancer screenings for high-risk men without imposing any cost-sharing requirements. This means that patients will not have to pay deductibles, copayments, or coinsurance for these screenings.
Definition of High Risk: While the bill does not specify the criteria for determining who is considered "high risk," it is generally understood that this may include factors such as family history, age, and other medical conditions that increase the likelihood of developing prostate cancer.
Insurance Coverage Requirements: The bill requires all health insurance providers operating within the jurisdiction to comply with this mandate, ensuring uniform access to screenings across different plans.
Men at High Risk for Prostate Cancer: The primary beneficiaries of this legislation would be men who are at increased risk for prostate cancer. By removing financial barriers, the bill aims to facilitate more frequent and timely screenings.
Health Insurance Providers: Insurance companies will need to adjust their policies and coverage plans to align with the new requirements set forth by the bill.
Healthcare Providers: Physicians and healthcare facilities that conduct prostate cancer screenings will likely see an increase in patient volume as more men take advantage of the no-cost screenings.
Current Status: As of now, HB 40 has been read for the first time and is under consideration by the House Committee on Insurance. The bill will need to pass through this committee before it can be debated and voted on by the full House.
Timeline: The introduction date of August 28, 2025, marks the beginning of the legislative process for this bill. Further actions and discussions will determine its progression through the legislative body.
Bill HB 40 represents a significant step towards improving healthcare access for men at high risk for prostate cancer by eliminating financial barriers to screening. If passed, it could lead to increased early detection rates, ultimately contributing to better health outcomes for this population.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
